September 13, 2019 / 5:27 AM / 10 days ago

BRIEF-Novartis Says Neuronal And Glial Filaments Have Potential To Support Management Of MS Patient

Sept 13 (Reuters) - Novartis Ag:

* DATA SHOW THAT NEURONAL AND GLIAL FILAMENTS, BIOMARKERS OF DISEASE ACTIVITY, HAVE POTENTIAL TO SUPPORT DECISION MAKING IN MANAGEMENT OF MULTIPLE SCLEROSIS (MS) PATIENT

* THESE DATA FURTHER SUPPORT USE OF NEURONAL AND GLIAL FILAMENTS AS GUIDES TO HELP PHYSICIANS AND PATIENTS WITH DISEASE MANAGEMENT Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below